Combivent UDV
Brand Name: Combivent UDV
Generic Name: Ipratropium Bromide + Salbutamol (as Sulfate)
Active
Registration Number
DRP-7891
Dosage Form
Solution For Inhalation
Issuance Date
February 11, 2025
Expiry Date
February 11, 2031
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength500 mcg/2.5 mg/2.5 mL
PackagingLDPE vial x 2.5 Ml (Box of 20's)
Classification
C
Classification
Prescription Drug (RX)
P
Pharmacologic
Adrenergic in Combination with Anticholinergic including Combination with Corticosteroid
A
Application
Renewal
Philippine FDA Classification
Active Ingredients (2)
Complete list of active ingredients in this pharmaceutical product.
Ipratropium BromideActive
Monograph: Ipratropium
Salbutamol (as Sulfate)Active
Monograph: R-salbutamol sulphate